PCAXOLB Stock Latest News
Private CompaniesOrganoid-Based Retinal Models Highlight Axol Bioscience’s Position in Ocular Research1d agoAXOLB
Private CompaniesAxol Bioscience Expands iPSC Service Capabilities With Scientist Hiring2d agoAXOLB
Private CompaniesAstrocyte-Focused ALS Research Underscores Demand for Axol Bioscience iPSC Models2d agoAXOLB
Private CompaniesAxol Bioscience Targets Growth Opportunities in iPSC-Based Neuroscience at SfN 20262d agoAXOLB
Private CompaniesAxol Bioscience Highlights iPSC-Based Neuroscience Portfolio Ahead of SfN 20263d agoAXOLBPrivate CompaniesCardiac Disease Modeling Highlights Axol Bioscience’s iPSC Platform Potential1w agoAXOLB
Private CompaniesAxol Bioscience Highlights Advanced Huntington’s Disease iPSC Model at Kyoto Symposium1w agoAXOLB
Private CompaniesAxol Bioscience Highlights Advanced ALS iPSC Tri‑Culture Disease Model1w agoAXOLB- Private CompaniesAxol Bioscience Showcases iPSC-Derived Neuronal Models at Nanion User Meeting1w agoAXOLB
- Private CompaniesAxol Bioscience Showcases iPSC-Derived Neuroscience Models at Kyoto Symposium1w agoAXOLB
- Private CompaniesAxol Bioscience Emphasizes Complex iPSC Co‑Culture Models for ALS Research2w agoAXOLB
Private CompaniesAxol Bioscience Supports Motor Neuron Disease Research With Cambridge Charity Event2w agoAXOLBPrivate CompaniesAxol Bioscience Supports Motor Neuron Disease Research Through Charity Event2w agoAXOLB
Private CompaniesAxol Bioscience Showcases iPSC Platforms at Drug Discovery Conference2w agoAXOLB- Private CompaniesAxol Bioscience Highlights Neurodegenerative Research Focus and Charity Initiative2w agoAXOLB
- Private CompaniesAxol Bioscience Showcases iPSC-Derived Models at ELRIG Drug Discovery 20262w agoAXOLB
Private CompaniesAxol Bioscience Highlights iPSC-Based Platforms at ELRIG Drug Discovery 20262w agoAXOLB
Private CompaniesAxol Bioscience Highlights Retinal Organoid Gene Therapy Research2w agoAXOLB